All News

2063 articles, sorted by publication time.

Gene Editing · global

Turning Prime Editing Into a Computable Reaction: OptiPrime Helps Correct KIF1A Mutations in the Mouse Brain

This model, which integrates molecular mechanisms with machine learning, not only predicts guide RNA performance but also seeks to circumvent resistance from mismatch repair. The research team achieved correction of more than 40% of the target mutations in the cerebral cortex of neonatal mice, but efficacy, safety, and durability remain to be demonstrated.

Medical Technology · us

Lung Biopsy Still in the Procedure Room, AI Gets the First Look: 1,000-Patient Study Completes Enrollment

The ON-SITE study enrolled 1,006 participants and collected more than 3,250 fresh bronchoscopic specimens in preparation for validating an imaging system designed to rapidly identify morphology suspicious for cancer at the point of sampling. However, completed enrollment does not mean its performance has been established; accuracy and clinical impact still await formal results.

Nephrology · global

Two-Year Kidney Function Curve Nearly Flat: Voyxact Phase 3 Trial Adds Long-Term Evidence in IgA Nephropathy

Compared with the continued decline in the placebo group, the annualized change in kidney function among patients treated with sibeprenlimab was close to zero. This result will serve as key evidence for converting the US accelerated approval to traditional approval, although full analyses and longer-term clinical outcomes remain to be confirmed.

Drug Regulation · eu

EU Formally Revokes Tavneos Marketing Authorization as Unreliable Pivotal Trial Data Reshape Drug’s Fate

From the recommendation to revoke authorization in June to the final decision, Tavneos has now been listed by the EU as a medicine whose authorization is no longer valid. At the heart of the controversy is not merely an analytical error, but the reassessment of patient data after unblinding, which pushed results that had originally failed to demonstrate superiority past the threshold for statistical significance.